ArticleAnnals of translational medicine2022

Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria.

De-Zhen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.